A convergent Psyduck design takes inspiration from Gen 1 classic Psyduck and its evolution Golduck, creating impressive ...
Convergent Therapeutics has circled up $90 million to develop next-gen radiopharmaceuticals in oncology, with its lead clinical program targeting prostate cancer. The Cambridge, Massachusetts-based ...
In a series of three extraordinary papers published between 2004 and 2013, Max D. Cooper and colleagues discovered a new type of adaptive immunity in jawless vertebrates. This revolutionary discovery ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback